In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
Q&AChina CDE Q&A | Biologics' R&D, Associated Review of APIs, Excipients, and Packaging Materials, Requirements for Changes, and More
Sep 05, 2022
INTERPRETATIONChina Abbreviated New Drug Application (ANDA) for Generic Drugs
May 18, 2022
Q&AFAQ on Rare Disease Drugs (Orphan Drugs) in China
Apr 07, 2022